☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Previously Untreated
AbbVie's Dual Regimen Receives EC's Approval for Patients with Previously Untreated Chronic Lymphocytic Leukemia
March 12, 2020
Roche Reports Results of Triple Combination Regimen in P-III IMspire150 Study for Previously Untreated BRAF V600 Mutation-Positive...
December 13, 2019
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE TN Study for Previously Untreated Chronic Lymphocytic Le...
December 9, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.